Filing Flows › American Well (AMWL) › R&D spending
American Well (AMWL) R&D spending by quarter
American Well's R&D spending was $9.6M in Q3 2026 (third quarter 2026), -7% from Q2 2026. Over the last 7 quarters it ranged from $9.6M (Q3 2026) to $22.1M (Q1 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $9.6M | -7% | -48% |
| Q2 2026 | $10.4M | -16% | -43% |
| Q1 2026 | $12.4M | -11% | -44% |
| Q4 2025 | $13.9M | -25% | — |
| Q3 2025 | $18.6M | +2% | — |
| Q2 2025 | $18.2M | -17% | — |
| Q1 2025 | $22.1M | — | — |
Q3 2026 at a glance
American Well, Q3 2026: revenue $49.0M (-13% year over year), operating margin -23.8%, net loss $11.0M, operating cash flow −$11.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is American Well's R&D spending?
American Well's R&D spending was $9.6M in Q3 2026 (third quarter 2026), -7% from Q2 2026.
How has American Well's R&D spending changed?
Over the last 7 quarters it ranged from $9.6M (Q3 2026) to $22.1M (Q1 2025).